OS1 Stock Overview
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Otsuka Holdings Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥39.60 |
| 52 Week High | JP¥40.00 |
| 52 Week Low | JP¥30.40 |
| Beta | 0.20 |
| 11 Month Change | 2.06% |
| 3 Month Change | 4.21% |
| 1 Year Change | 20.00% |
| 33 Year Change | 19.28% |
| 5 Year Change | 28.07% |
| Change since IPO | 136.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| OS1 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 1.0% | -1.3% | 0.8% |
| 1Y | 20.0% | -17.7% | 6.1% |
Return vs Industry: OS1 exceeded the German Pharmaceuticals industry which returned -17.7% over the past year.
Return vs Market: OS1 exceeded the German Market which returned 6.1% over the past year.
Price Volatility
| OS1 volatility | |
|---|---|
| OS1 Average Weekly Movement | 3.7% |
| Pharmaceuticals Industry Average Movement | 5.4% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in DE Market | 10.5% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: OS1 has not had significant price volatility in the past 3 months.
Volatility Over Time: OS1's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1921 | 34,388 | Tatsuo Higuchi | www.otsuka.com |
Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, and insecticide and toiletry products.
Otsuka Holdings Co., Ltd. Fundamentals Summary
| OS1 fundamental statistics | |
|---|---|
| Market cap | €21.57b |
| Earnings (TTM) | €789.34m |
| Revenue (TTM) | €11.99b |
27.3x
P/E Ratio1.8x
P/S RatioIs OS1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OS1 income statement (TTM) | |
|---|---|
| Revenue | JP¥2.09t |
| Cost of Revenue | JP¥626.25b |
| Gross Profit | JP¥1.46t |
| Other Expenses | JP¥1.33t |
| Earnings | JP¥137.56b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 31, 2024
| Earnings per share (EPS) | 253.55 |
| Gross Margin | 70.03% |
| Net Profit Margin | 6.58% |
| Debt/Equity Ratio | 4.7% |
How did OS1 perform over the long term?
See historical performance and comparison